Quantification of blood betel quid alkaloids and urinary 8-hydroxydeoxyguanosine in humans and their association with betel chewing habits

Journal of Analytical Toxicology

Volumn 34, Issue 6, 2010, Pages 325-331

  Wu, I Chen ^a   Chen, Ping Ho ^b,c   Wang, Chien Jen ^b   Wu, Deng Chyang ^a,d   Tsai, Shih Meng ^d   Chao, Mu Rong ^e   Chen, Bai Hsiun ^a   Lee, Hei Hwa ^a   Lee, Chien Hung ^c   Ko, Ying Chin ^b,c,d  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ARECAIDINE; ARECOLINE; 8-HYDROXY-2'-DEOXYGUANOSINE; BIOLOGICAL MARKER; CENTRAL STIMULANT AGENT; DEOXYGUANOSINE; DRUG DERIVATIVE;

ADULT; ARTICLE; BETEL NUT; BETEL QUID; CARCINOGENESIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG URINE LEVEL; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MALE; MASTICATION; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; ADDICTION; BLOOD; MIDDLE AGED; URINE;

PIPER BETEL;

ADULT; ARECA; ARECOLINE; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM STIMULANTS; DEOXYGUANOSINE; FEMALE; HUMANS; MALE; MIDDLE AGED; SUBSTANCE-RELATED DISORDERS;

EID: 78049505801     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/34.6.325     Document Type: Article

References (37)

1. B.J. Boucher and N. Mannan. Metabolic effects of the consumption of Areca catechu. Addict. Biol. 7: 103-110 (2002).
2. P.C. Gupta and S. Warnakulasuriya. Global epidemiology of areca nut usage. Addict. Biol. 7: 77-83 (2002).
3. Y.C. Ko, T.A. Chiang, S.J. Chang, and S.F. Hsieh. Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors. J. Oral Pathol. Med. 21: 261-264 (1992).
4. M.S. Yang, I.H. Su, J.K. Wen, and Y.C. Ko. Prevalence and related risk factors of betel quid chewing by adolescent students in southern Taiwan. J. Oral Pathol. Med. 25: 69-71 (1996).
5. P.S. Ho, Y.C. Ko, Y.H. Yang, T.Y. Shieh, and C.C. Tsai. The incidence of oropharyngeal cancer in Taiwan: an endemic betel quid chewing area. J. Oral Pathol. Med. 31: 213-219 (2002).
6. P.H. Chen, C.C. Tsai, Y.C. Lin, Y.C. Ko, Y.H. Yang, T.Y. Shieh, P.S. Ho, C.M. Li, A. Min-Shan Ko, and C.H. Chen. Ingredients contribute to variation in production of reactive oxygen species by areca quid. J. Toxicol. Environ. Health A 69: 1055-1069 (2006).
7. M.S. Yang, C.H. Lee, S.J. Chang, T.C. Chung, E.M. Tsai, A.M. Ko, and Y.C. Ko. The effect of maternal betel quid exposure during pregnancy on adverse birth outcomes among aborigines in Taiwan. Drug Alcohol Depend. 95: 134-139 (2008).
8. C.F. Lin, J.D. Wang, P.H. Chen, S.J. Chang, Y.H. Yang, and Y.C. Ko. Predictors of betel quid chewing behavior and cessation patterns in Taiwan aborigines. BMC Public Health 6: 271 (2006).
9. A.M. Yen, Y.H. Chiu, L.S. Chen, H.M. Wu, C.C. Huang, B.J. Boucher, and T.H. Chen. A population-based study of the association between betel-quid chewing and the metabolic syndrome in men. Am. J. Clin. Nutr. 83: 1153-1160 (2006).
10. J.Y. Guh, H.C. Chen, J.F. Tsai, and L.Y. Chuang. Betel-quid use is associated with heart disease in women. Am. J. Clin. Nutr. 85: 1229-1235 (2007).
11. T.Y. Lan, W.C. Chang, Y.J. Tsai, Y.L. Chuang, H.S. Lin, and T.Y. Tai. Areca nut chewing and mortality in an elderly cohort study. Am. J. Epidemiol. 165: 677-683 (2007).
12. R.J. Sullivan, S. Andres, C. Otto, W. Miles, and R. Kydd. The effects of an indigenous muscarinic drug, Betel nut (Areca catechu), on the symptoms of schizophrenia: a longitudinal study in Palau, Micronesia. Am. J. Psychiatry 164: 670-673 (2007).
13. I.C.Wu, C.Y. Lu, F.C. Kuo, S.M. Tsai, K.W. Lee, W.R. Kuo, Y.J. Cheng, E.L. Kao, M.S. Yang, and Y.C. Ko. Interaction between cigarette, alcohol and betel nut use on esophageal cancer risk in Taiwan. Eur. J. Clin. Invest 36: 236-241 (2006).
14. J.F. Tsai, J.E. Jeng, L.Y. Chuang, M.S. Ho, Y.C. Ko, Z.Y. Lin, M.Y. Hsieh, S.C. Chen, W.L. Chuang, L.Y. Wang, M.L. Yu, and C.Y. Dai. Habitual betel quid chewing and risk for hepatocellular carcinoma complicating cirrhosis. Medicine (Baltimore) 83: 176- 187 (2004).
15. C.H. Lee, Y.C. Ko, H.L. Huang, Y.Y. Chao, C.C. Tsai, T.Y. Shieh, and L.M. Lin. The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan. Br. J. Cancer 88: 366-372 (2003).
16. Y.C. Ko, Y.L. Huang, C.H. Lee, M.J. Chen, L.M. Lin, and C.C. Tsai. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J.Oral Pathol.Med. 24: 450-453 (1995).
17. K.W. Lee, W.R. Kuo, S.M. Tsai, D.C. Wu, W.M. Wang, F.M. Fang, F.Y. Chiang, K.Y. Ho, L.F. Wang, C.F. Tai, E.L. Kao, S.H. Chou, C.H. Lee, C.Y. Chai, and Y.C. Ko. Different impact from betel quid, alcohol and cigarette: risk factors for pharyngeal and laryngeal cancer. Int. J. Cancer 117: 831-836 (2005).
18. IARC, Betel-quid and areca-nut chewing and some areca-nutderived nitrosamines, IARC Monogr Eval Carcinog Risks Hum, 2004.
19. IARC. Betel-quid and areca-nut chewing. IARC Monogr. Eval. Carcinog. Risk Chem. Hum. 37: 145-146 (1985).
20. J.H. Jeng, M.C. Chang, and L.J. Hahn. Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol. 37: 477-492 (2001).
21. N.S. Chu. Effects of Betel chewing on the central and autonomic nervous systems. J. Biomed. Sci. 8: 229-236 (2001).
22. M. Dizdaroglu, P. Jaruga, M. Birincioglu, and H. Rodriguez. Free radical-induced damage to DNA: mechanisms and measurement. Free Rad. Biol. Med. 32: 1102-1115 (2002).
23. U. Nair, H. Bartsch, and J. Nair. Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis 19: 251-262 (2004).
24. U.J. Nair, G. Obe, M. Friesen, M.T. Goldberg, and H. Bartsch. Role of lime in the generation of reactive oxygen species from betel-quid ingredients. Environ. Health Perspect. 98: 203-205 (1992).
25. H. Kasai. Analysis of a form of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat. Res. 387: 147-163 (1997).
26. C.W. Hu, C.J. Wang, L.W. Chang, and M.R. Chao. Clinical-scale high-throughput analysis of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine by isotope-dilution liquid chromatographytandem mass spectrometry with on-line solid-phase extraction. Clin. Chem. 52: 1381-1388 (2006).
27. M.J. Hayes, L. Khemani, M. Bax, and D. Alkalay. Quantitative determination of arecoline in plasma by gas chromatography chemical ionization mass spectrometry. Biomed. Environ. Mass Spectrom. 18: 1005-1009 (1989).
28. S. Pichini, M. Pellegrini, R. Pacifici, E. Marchei, J. Murillo, C. Puig, O. Vall, and O. Garcia-Algar. Quantification of arecoline (areca nut alkaloid) in neonatal biological matrices by high-performance liquid chromatography/electrospray quadrupole mass spectrometry. Rapid Commun. Mass Spectrom. 17: 1958-1964 (2003).
29. E. Marchei, A. Durgbanshi, S. Rossi, O. Garcia-Algar, P. Zuccaro, and S. Pichini. Determination of arecoline (areca nut alkaloid) and nicotine in hair by high-performance liquid chromatography/electrospray quadrupole mass spectrometry. Rapid Commun. Mass Spectrom. 19: 3416-3418 (2005).
30. S. Cox, I. Piatkov, E.R. Vickers, and G. Ma. High-performance liquid chromatographic determination of arecoline in human saliva. J. Chromatogr. A 1032: 93-95 (2004).
31. M. Pellegrini, E. Marchei, S. Rossi, F. Vagnarelli, A. Durgbanshi, O. Garcia-Algar, O.Vall, and S. Pichini. Liquid chromatography/electrospray ionization tandem mass spectrometry assay for determination of nicotine and metabolites, caffeine and arecoline in breast milk. Rapid Commun. Mass Spectrom. 21: 2693-2703 (2007).
32. C.Y. Chuang, C.C. Lee, Y.K. Chang, and F.C. Sung. Oxidative DNA damage estimated by urinary 8-hydroxydeoxyguanosine: influence of taxi driving, smoking and areca chewing. Chemosphere 52: 1163-1171 (2003).
33. R.H. Wong, C.W. Hu, C.Y. Yeh, M.R. Chao, C.C. Chen, J.H. Huang, S.H. Chang, S.I. Lee, and H.S. Lee. Sulfotransferase 1A1 and glutathione S-transferase P1 genetic polymorphisms modulate the levels of urinary 8-hydroxy-2'-deoxyguanosine in betel quid chewers. Arch. Toxicol. 82(5): 313-321 (2008).
34. L.L. Wu, C.C. Chiou, P.Y. Chang, and J.T. Wu. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin. Chim. Acta 339: 1-9 (2004).
35. S. Giri, J.R. Idle, C. Chen, T.M. Zabriskie, K.W. Krausz, and F.J. Gonzalez. A metabolomic approach to the metabolism of the areca nut alkaloids arecoline and arecaidine in the mouse. Chem. Res. Toxicol. 19: 818-827 (2006).
36. J. Saunders, G.A. Showell, R.J. Snow, R. Baker, E.A. Harley, and S.B. Freedman. 2-Methyl-1,3-dioxaazaspiro(4.5)decanes as novel muscarinic cholinergic agonists. J. Med. Chem. 31: 486-491 (1988).
37. O. Nieschulz and P. Schmersahl. On the pharmacology of active materials from betel. 2. Transformation of arecoline to arecaidine. Arzneimittelforschung 18: 222-225 (1968).